Doctor-patient trust is key to unlocking AI's potential to improve healthcare in Australia, finds Philips' Future Health Index Report
Whilst patients and providers see the potential for AI to address major challenges such as care delays and staff burnout, they believe its primary role should be to empower clinicians, allowing for more meaningful, human-centric care.
' This 10th edition of the Future Health Index gives us the clearest picture yet of what Australians want for their healthcare: technology must serve the human connection', said Shehaan Fernando, interim Managing Director of Philips Australia and New Zealand. " For patients, building trust is as important as building technology. At Philips, we are committed to a human-centric vision for AI that empowers clinicians and strengthens the doctor-patient relationship that Australians value'.
Patients welcome tech, but protect personal relationships
The report uncovers a key tension in Australian attitudes towards technology. Whilst a majority (66%) of Australians welcome new technology if it improves the quality of their care, more than half (53%) express concern that it could lead to less direct interaction with their doctors.
This desire for human connection is amplified by Australia's long-standing reliance on GP services as the foundation of the healthcare system. The findings suggest patients see AI's ideal role as a powerful support tool that handles administrative tasks, streamlines data access, and ultimately frees up GPs to engage in more in-depth, meaningful consultations. In Australia, three in four healthcare professionals (74%) report losing clinical time due to incomplete or inaccessible patient data, with one fifth of these (19%) losing more than 45 minutes per shift – adding up to 23 full days lost per healthcare professional each year[1]. AI's ability to manage and streamline patient data holds the key to reclaiming this time, allowing healthcare professionals to dedicate more focus to direct patient care.
Doctors as trusted guides to AI
When it comes to navigating the complexities of AI, Australians place their trust in their healthcare professionals. 79% of Australians would be most comfortable receiving information about AI in their care from their doctor, surpassing news outlets (48%) and social media (31%). This underscores the indispensable role of clinicians in guiding public acceptance and integration of AI.
However, the report also notes that healthcare professionals themselves have questions, with 77% concerned or unclear about liability for AI errors. Australians are less optimistic about AI's benefits (43%) compared to their healthcare providers (84%), highlighting a critical trust gap.
' As clinicians, we see the incredible potential for AI to help us diagnose earlier and create more personalised treatment plans', said Dr Tim Bowles, Head of Department - HIVE (Health in a Virtual Environment), at East Metropolitan Health Service (EMHS) in Western Australia. " AI can empower us to spend less time on administration and more time with our patients, ensuring technology elevates, rather than diminishes, the human element of care'.
Philips' Commitment: Driving Human-Centred Innovation
Philips' expertise in virtual hospital services and clinical command centres aligns with EMHS's efforts to improve patient-centred care and proactively detect the risk of patient deterioration. This collaboration, featuring the HIVE program and the deployment of a Clinical Command Centre solution leveraging machine learning and predictive analytics, has demonstrated significant patient outcomes.
'By integrating AI into our clinical workflows, we've been able to detect patient deterioration earlier, intervene faster, and ultimately deliver safer, more effective care. AI has become a vital tool in supporting our clinicians and improving outcomes when and where it matters most.'
— Adam Lloyd, Area Director Community & Virtual Care East Metropolitan Health Service
Data indicates the Clinical Command Centre has led to a 26% reduction in patient mortality[2], a 30% reduction in length of stay[3], and has helped 15% of patients be discharged home faster[4]. Furthermore, the program facilitated over 10,000 clinical interactions over a 12-month period, with 10% being for urgent or life-threatening reasons, and 64% of all interactions occurring after hours or on weekends. By integrating technology seamlessly into clinical workflows, Philips helps to augment the skills of healthcare professionals and improve patient care when it's needed most.
'Our long-term vision is to deliver responsible, human-centric AI that addresses the real-world challenges of patients and providers', said Shehaan Fernando, interim Managing Director of Philips Australia and New Zealand. 'By partnering with the medical community, we can ensure that innovation builds trust, improves outcomes, and supports a future of providing better care for more people'.
For more information, or to download the full FHI 2025 Australia report, visit www.philips.com/futurehealthindex-2025.
[1] FHI 2025 Australia report: Based on an eight-hour shift, working 250 days per year. This amounts to 187.50 hours lost per healthcare professional on average.
[2] Lilly CM, et al. A Multi-center Study of ICU Telemedicine Reengineering of Adult Critical Care. CHEST. 2014; 145(3): 500-7.
[3] Lilly CM, et al. Hospital Mortality, Length of Stay and Preventable Complications Among Critically Ill Patients Before and After Tele-ICU Reengineering of Critical Care Processes. JAMA. June 2011; 305(21) 2175-83.[5] Impact of an Intensive Care Unit Telemedicine Program on a Rural Health Care System. Zawada, et al. Postgrad Med J, 2009; 121(3):160-170.
[4] Impact of an Intensive Care Unit Telemedicine Program on a Rural Health Care System. Zawada, et al. Postgrad Med J, 2009; 121(3):160-170.
Hashtag: #Philips
The issuer is solely responsible for the content of this announcement.
Royal Philips
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips ' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2024 sales of EUR 18.2 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About the Future Health Index
The Future Health Index is commissioned by Philips. In its 10th edition, the Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care for more people. Two quantitative surveys were carried out among more than 1,900 healthcare professionals and more than 16,000 patients in 16 countries. The surveys were conducted from December 2024 to April 2025. For more information, or to download the full FHI 2025 Global Report, visit www.philips.com/futurehealthindex-2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. AT&T to pay $177 million in data breach settlement. Here's how to claim up to $5,000 Wells Fargo is rolling out company wide AI. It says everyone from branch tellers to investment bankers will benefit Want to get smarter? Neuroscience says 5 simple steps significantly boost memory, learning, and cognition Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock, although IPO calendar websites say the listing is expected this week. The company declined to comment on the timeline when reached by Fast Company. This post originally appeared at to get the Fast Company newsletter: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
an hour ago
- CBS News
Yidu Tech: Bridging Healthcare Gaps with AI-Powered Healthcare Ecosystem
Across the globe, disparities in medical resources and digital infrastructure have created significant variations in healthcare quality. The fragmentation of data systems, often referred to as "data silos," remains a major challenge. Over a decade ago, Yidu Tech set out with a bold mission, to make precision healthcare accessible to everyone, and has remained committed to this goal ever since. Laying the data foundation: Driving healthcare innovation with AI Today's global healthcare systems face complex challenges, including uneven resource allocation and inconsistent data standards. While developed regions continue to advance, underserved areas struggle with fragmented services and insufficient digital infrastructure. This results in poor continuity of care and inefficiencies in service delivery. To overcome this, Yidu Tech has placed data standardization at the core of its strategy. By introducing internationally recognized clinical terminologies and diagnostic coding standards, Yidu Tech has built a unified data architecture, exemplified by YiduCore, which ensures consistency and interoperability across diverse healthcare data sources. YiduCore has processed 6 billion authorized medical records to date. It has built a comprehensive disease knowledge graph that covers virtually all known human diseases, and, in collaboration with leading medical experts, has developed over 20 high-value specialized disease datasets —further solidifying the foundation for intelligent medical applications. Building on this, Yidu Tech has developed an AI-powered medical assistant platform that facilitates real-time appointment scheduling, alleviating in-person congestion. Video consultations bridge geographical gaps and offer patients scientifically-grounded clinical recommendations. Furthermore, by automating routine health inquiries, the AI system aims to reduce healthcare professionals' workloads while enabling patients to receive timely, remote guidance—ultimately minimizing unnecessary clinic visits and significantly improving resource efficiency. From China to the world: Illuminating a global smart health network Yidu Tech has already established partnerships in China, Singapore, Brunei, Japan and the U.S. In Brunei in particular, the company, working alongside strong government backing and public health strategy, has successfully implemented a real-time national health management system, offering a scalable model for innovation in public healthcare. Looking ahead, Yidu Tech says it will continue to expand its global collaborations, co-developing integrated AI and healthcare solutions. It aims to localize and scale its intelligent health systems across various regions, promote scientific advancement through real-time data and empower new understanding and treatment pathways in life sciences. Open collaboration, intelligent future: Building a new global health framework Healthcare is inherently complex and multifaceted. Yidu Tech firmly believes that placing patients at the center—combined with robust AI infrastructure and global adaptability—is key to achieving truly sustainable healthcare. Through open collaboration and a data-driven technological ecosystem, Yidu Tech is working alongside global partners to build a more inclusive, intelligent health future where care is accessible and beneficial to all.
CNN
an hour ago
- CNN
Los Angeles wildfires may be linked to 440 deaths, new research estimates
The wildfires that ravaged Los Angeles earlier this year — burning entire neighborhoods to the ground, straining firefighting resources and forcing tens of thousands of people to flee their homes — may have led to hundreds more deaths than were recorded, a new study suggests. While officials reported that the Palisades and Eaton fires directly killed at least 30 people when they incinerated parts of Los Angeles County, the blazes may be linked to 410 additional deaths from January 5 to February 1, according to research published Wednesday in the The Journal of the American Medical Association. That would make for a total of 440 wildfire-related deaths, according to the study. 'These additional deaths likely reflect a combination of factors, including increased exposure to poor air quality and health care delays and interruptions,' the study says. The wildfires' impact on his loved ones motivated Andrew Stokes, a mortality demographer and one of the authors of the study, to probe for excess deaths. 'Having had many family and friends who were directly affected made me feel compelled to look into this further, using my expertise as a demographer and a person who studies mortality statistics,' the Boston University associate professor told CNN. The new findings highlight the need to quantify just how deadly wildfires and other climate-related emergencies can be beyond direct fatalities. The emergencies can have long-term health effects that extend well beyond the disaster itself, experts say. Years ago, Stokes evaluated the excess deaths during the pandemic after many deaths went uncounted, he said. After developing models to understand the true toll of the virus, Stokes used that expertise to look at the true mortality burden of natural disasters such as the Los Angeles wildfires. Along with deaths directly related to the wildfire, the researchers counted deaths partially and indirectly attributed to the wildfires. That includes lung or heart conditions exacerbated by smoke or stress, disruptions to health systems and mental health impacts, according to the study. To conduct the study, the researchers compared recorded deaths in Los Angeles County from January to February with figures from previous years, excluding 2020 to 2023 due to the COVID-19 pandemic. That helped researchers estimate how many deaths would have been expected in that time period had no wildfires occurred, Stokes said. They then calculated excess deaths as the difference between observed and expected deaths, according to the study. 'In Los Angeles County, weekly deaths consistently exceeded expected deaths during the period from January 5 to February 1, 2025,' the study says. A total of 6,371 deaths were observed in the county, compared with 5,931 expected deaths, according to the study. This means that nearly 7% of the recorded deaths in Los Angeles County were excess deaths linked to the wildfires. Stokes said he was 'really surprised and alarmed' at the findings. 'The magnitude of the underreporting in the official data is just very severe,' he said. But he hopes that quantifying the excess deaths can spur authorities to provide more assistance to those still grappling with the devastation. The researchers note that the data is preliminary and the toll could grow. 'That 440 value that we estimate is clearly the lower bound, because we only look at the first weeks after the wildfire started,' Stokes said. 'These medium and long- term effects … could manifest over time as people develop wildfire related diseases.' Future studies should investigate the longer-term health impacts of the wildfires and the specific causes of excess wildfire deaths, the researchers said.
